Activation of mammalian Toll-like receptors by endogenous agonists

被引:116
|
作者
Johnson, GB [1 ]
Brunn, GJ [1 ]
Platt, JL [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
关键词
inflammation; polysaccharides; Toll; endogenous; immunology; innate immunity; mammalian; Toll-like receptors; heparan sulfate; hyaluronic acid; lipopolysaccharide; necrosis; matrix; infection; R genes; Drosophila; enzymatic cascades; coagulation; degradation; pathogen-associated molecular patterns; surveillance; adaptive immunity; metastasis; ischemia; atherosclerosis; LIPOPOLYSACCHARIDE-BINDING PROTEIN; DORSAL-VENTRAL POLARITY; TUMOR-NECROSIS-FACTOR; HEAT-SHOCK PROTEINS; NF-KAPPA-B; INNATE IMMUNE RECOGNITION; GRAM-NEGATIVE BACTERIA; SUBENDOTHELIAL EXTRACELLULAR-MATRIX; HEPARAN-SULFATE PROTEOGLYCANS; MIMETIC SIGNAL-TRANSDUCTION;
D O I
10.1615/CritRevImmunol.v23.i12.20
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors activate innate and adaptive immune systems in mammals. This ancient family of receptors has been evolving since before the taxonomic split between the plant and animal kingdoms. The discovery of the mammalian Toll-like receptors was heralded as confirmation of a predicted biological system explicitly designed to detect exogenous molecules from micro-organisms. However, there is accumulating evidence that Toll-like receptors also detect endogenous agonists, such as the degradation products of macromolecules, products of proteolytic cascades, intracellular components of ruptured cells, and products of genes that are activated by inflammation. Here we review endogenous models of Toll-like receptor activation, a subject of extensive debate. Endogenous activation of mammalian Toll-like receptors may provide key insights for the treatment of multiple conditions, from atherosclerosis to transplant rejection.
引用
收藏
页码:15 / 44
页数:30
相关论文
共 50 条
  • [21] Therapeutic applications of toll-like receptors (TLRs) agonists in AML
    Ye Peng
    Yanzhong Wang
    Manling Wang
    Jianping Lan
    Yirui Chen
    Clinical and Translational Oncology, 2022, 24 : 2319 - 2329
  • [22] Correction: Corrigenda: Antisense and siRNA as agonists of Toll-like receptors
    Sudhir Agrawal
    Ekambar R Kandimalla
    Nature Biotechnology, 2005, 23 (1) : 117 - 117
  • [23] Expression and function of toll-like receptors in eosinophils: Activation by toll-like receptor 7 ligand
    Nagase, H
    Okugawa, S
    Ota, Y
    Yamaguchi, M
    Tomizawa, H
    Matsushima, K
    Ohta, K
    Yamamoto, K
    Hirai, K
    JOURNAL OF IMMUNOLOGY, 2003, 171 (08): : 3977 - 3982
  • [24] Activation of airway epithelial cells by toll-like receptor agonists
    Sha, Q
    Truong-Tran, AQ
    Plitt, JR
    Beck, LA
    Schleimer, RP
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 31 (03) : 358 - 364
  • [25] Activation and control of toll like receptors by endogenous molecules
    Brunn, Gregory J.
    Platt, Jeffrey L.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (02) : A5 - A5
  • [26] Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists
    Manrique, Soraya Zorro
    Dominguez, Ana L.
    Mirza, Noweeda
    Spencer, Christopher D.
    Bradley, Judy M.
    Finke, James H.
    Lee, James J.
    Pease, Larry R.
    Gendler, Sandra J.
    Cohen, Peter A.
    ONCOTARGET, 2016, 7 (28) : 42919 - 42942
  • [27] Toll-like receptors, endogenous ligands, and systemic autoimmune disease
    Rifkin, IR
    Leadbetter, EA
    Busconi, L
    Viglianti, G
    Marshak-Rothstein, A
    IMMUNOLOGICAL REVIEWS, 2005, 204 : 27 - 42
  • [28] Toll-like receptors
    Moresco, Eva Marie Y.
    LaVine, Diantha
    Beutler, Bruce
    CURRENT BIOLOGY, 2011, 21 (13) : R488 - R493
  • [29] Toll-like receptors
    Takeda, K
    Kaisho, T
    Akira, S
    ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 : 335 - 376
  • [30] A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors
    Sloane, Jacob A.
    Blitz, Daina
    Margolin, Zachary
    Vartanian, Timothy
    NEUROMOLECULAR MEDICINE, 2010, 12 (02) : 149 - 163